In a study investigating the treatment of MCC cell lines with BET protein inhibitor JQ1, a significant reduction in c-Myc expression was observed in MCC cell lines, accompanied by a dose-dependent inhibition of cell proliferation [32]. The gene discussed is MYC; the disease is Merkel cell skin cancer.